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Abstract 
Respecting the wishes of an adequately informed patient should be a priority in any health structure. A patient with advanced or terminal 
cancer should be allowed to express their will during the most important phases of their illness. Unfortunately, this is seldom the case, 
and in general instructions regarding an individual's medical care preferences, i.e., their 'living will', expressed when healthy, often 
change with the onset of a serious illness. 
At the European Institute of Oncology (IEO), a clinical study is ongoing to verify whether, during clinical practice, the patient is adequately 
informed to sign an 'informed consent', in a fully aware manner, that will allow the patient and doctor to share in the decisions regarding 
complex treatment strategies (living will). A further aim of the study is to verify if health workers, both in hospital and at home, respect 
the patient's will. 
The observational study 'Respecting the patient's wishes: Correlation between administered treatment and that accepted by the patient in 
their Living Will' was approved by the IEO Ethical Committee in April 2008. 
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Study design 
All the patients enrolled in the study will be informed in a way 
that ensures adequate comprehension ('giving detailed 
information' is not enough; it is necessary to ensure that the 
patient understands what is involved). 
In the case of surgical patients, at the first visit (usually as an 
outpatient), a research surgeon indicates on the admission form 
for complex surgery whether the patient fulfils all the inclusion 
criteria for the study and adequately explains the objectives of 
the study to the patient for the first time. Subsequently, during 
the pre-admission visit, the patient re-discusses their complex 
treatment with the research anaesthesiologist. Finally on the 
day of admission, patients are asked whether they want to 
participate in the study previously detailed. If they are 
interested, a structured interview is organized with the Head of 
the Division (or other appointed physician), the Head Nurse (or 
other appointed nurse) and (if the patient consents and the 
researcher finds it necessary) a family member/friend or general 
practitioner. If at the end of this interview the patient agrees to 
participate in the study, they sign an ad-hoc informed-consent 
form and fill in a questionnaire; research assistants are 
available to help, should the patient request it. When the patient 
is discharged, a case report form (CRF) is completed and 
signed by both the Head of the Division and the Head Nurse. 
In the case of medical patients, information regarding advance 
planning of complex treatments is also given at similar time 
points, starting with the first visit and finally, if the patient 
accepts, at the point when he gives his informed opinions in the 
questionnaire. When the patient is discharged, a case report 
form is filled in and signed by both the Head of the Division and 
the Head Nurse/Head Technician. 
The patient's living will is compared to the actual treatments 
administered as registered on the CRF by the responsible 
physician at the end of treatment. 
 
Materials and methods 
After being adequately informed, patients sign an 'informed 
consent form for the participation in the study' and fill out a 
questionnaire at the following 'critical' moments: 
•  after the communication of a diagnosis of serious, 
advanced, probably incurable cancer; 
•  before complex surgery; 
•  before further complex medical treatment. 
In order to freely express their consent and to participate in the 
study, patients must be of sound mind. 
 
Results 
During the 16 months of the study (February 2008 to June 
2009), the following 15 patients were enrolled: 
(1)  A 55-year-old male with voluminous recurrent 
retroperitoneal sarcoma infiltrating a horseshoe kidney 
and the colon. Surgery performed: mass resection, 
partial nephrectomy and colon resection. Discharge 
after 24 days; at present (after 24 months) the patient 
is free of disease (see Figure 1a and b and Figure 2). 
(2)  An 86-year-old female with symptomatic liver 
metastasis to the sixth segment. Surgery: R0 liver 
resection. Ten-month follow-up: the patient is 
asymptomatic and free of disease. 
(3) A 69-year-old female with incisional hernia and 
peristomal fistula after total pelvectomy for sigmoid 
cancer infiltrating the bladder. Surgery: hernia repair 
and re-colostomy. 
(4)  A 55-year-old male with rectal cancer recurrence after 
previous anterior rectal resection (after neoadjuvant 
chemoradiotherapy). Surgery: re-resection according 
to Hartman + Intra-Operative RadioTherapy (IORT). 
(5) A 55-year-old female diagnosed with distal rectal 
neoplasia, involving the sphincter with liver and lung 
metastases. Surgery: robotic Miles abdominal 
amputation after neoadjuvant chemotherapy. 
(6)  A 70-year-old male diagnosed with pancreatic head 
cancer (six months before, biliar endoprosthesis for 
obstructive jaundice). Surgery: cephaloduodeno 
pancreatectomy for pancreatic cancer pT3 pN1. 
(7)  A 35-year-old male Jehovah’s Witness diagnosed with 
a symptomatic voluminous cystic haemangioma of the 
second–third liver segment. Surgery: liver resection 
(without blood supply for transfusion). 
(8) A 65-year-old female diagnosed with a voluminous 
retroperitoneal sarcoma behind and below the liver, 
massively infiltrating the inferior cava vein. Surgery: 
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(a)
 
(b) 
 
Figure 1a and b: Voluminous retroperitoneal sarcoma in a patient with horseshoe kidney (before surgery)—patient 1.
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Figure 2: Abdominal CT after surgery—patient 1. 
 
Figure 3: Pre-operative CT—patient 8.
mass resection with substitution of the inferior cava 
vein with vascular prosthesis and right nephrectomy 
(see Figures 3 and 4). 
 
(9) A 72-year-old female diagnosed pancreatic head 
carcinoma without jaundice. Surgery: cephaloduodeno 
pancreatectomy (see Figure 5a and b). 
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Figure 4: Post-operative CT scan—patient 8. 
(a) 
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(b) 
 
Figure 5a and b: Histology of neuroendocrine tumour—patient 9.
(10)  A 71-year-old male previously treated with HIFU + 
external radiotherapy for prostate cancer. Diagnosed 
with a neoplasia to the distal rectum, the patient 
underwent Miles abdominal amputation with terminal 
colostomy. 
(11) A 59-year-old female diagnosed with a stenosis 4 cm 
from the anus, with incontinence and tenesmus after 
colorectal surgery (rectosigmoid resection + liver 
resection + removal of colonic recurrence). Surgery: 
Hartmann resection. 
(12)  A 45-year-old female with a symptomatic voluminous 
retroperitoneal sarcoma massively infiltrating the 
inferior cava vein, deemed surgically inoperable 
elsewhere. Surgery: mass resection with cava 
reconstruction (see Figure 6, video clip). 
(13) A 56-year-old male diagnosed adenocarcinoma to the 
caecum and rectum in a patient with familial colonic 
polyposis and symptomatic brain artero–venous 
malformation (epileptic crises). Surgery: total 
proctocolectomy with ileal-anal pouch. 
(14)  A 76-year-old male diagnosed voluminous incisional 
hernia after total gastrectomy for gastric cancer. 
Surgery: hernia repair with mesh. 
(15) A 56-year-old male diagnosed with a local recurrence, 
after previous emicolectomy, infiltrating the left ureter 
(with left ureterohydronephrosis) and colon, 
inseparable from the left iliac vessels. Surgery: 
recurrence resection with left ureteronephrectomy. The 
patient died on the seventh day after surgery, just 
before discharge (probable massive pulmonary 
embolism). 
(16) A 63-year-old man diagnosed with stenosing neoplasia 
to the distal third of the oesophagus, serious 
malnutrition; aneurism to the abdominal aorta. Surgery: 
oesophageal resection with oesophago-gastric plastic 
reconstruction. 
(17)  A 77-year-old male diagnosed with recent 
haematemesis due to ulcerated gastric cancer; serious 
myocardiac stroke during hospitalisation for tumour 
bleeding (strain test with very low threshold because of 
myocardiac damage). Surgery: total gastrectomy. 
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To view this video click here: 
 
http://www.ecancermedicalscience.com/view-article.asp?doi=10.3332/ecancer.2009.158
Video clip. Surgical procedure of mass resection with cava reconstruction. Patient 12 
Figure 6: CT scan before surgery—patient 12.
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Discussion 
While examining the questionnaires filled in by the 15 patients, 
the researcher group (physicians and nurses from IEO) asked 
the following questions: 
•  Were the patients informed correctly? 
•  Can their wills, as expressed in the questionnaires, be 
considered 'informed' and 'binding' for health workers? 
•  Were their written wills respected at least during 
treatment at IEO? 
•  How should physicians and nurses behave in cases of 
temporary or permanent patient incapacity, when there 
is disagreement between the treatment intention of the 
IEO personnel and the patient's written will? 
•  How much should the trustee's opinion, who 
was chosen by the patient before treatment, count in 
cases of temporary or permanent patient incapacity? 
Pondering these issues certainly helped physicians and nurses 
involved in the study to grow both from a human and 
professional point of view. 
Both patients and their families appreciated the questions asked 
in the questionnaire. The meetings with physicians to fill out the 
questionnaire facilitated sharing choices and established a 
strong 'therapeutic alliance'. This allowed constructive 
communication where patients and their families relied on 
physicians and nurses who empathically cared for the patient. 
In the only adverse case (sudden death of the patient just 
before hospital discharge), the discussions involved in 
establishing the living will prior to surgery, helped to create a 
mutual understanding and support between family and health 
workers at this difficult time. 
In the short lifespan of the IEO, the will of the patient has always 
been respected. The identification of a trustee, a person close 
to the patient, has often facilitated the collaboration between the 
patient and their family and health workers. 
The commitment of all clinical researchers involved in the study 
also led to a revision of the process for the acquisition of 
informed consent. The previous approach, often limited to a 
signature on a standard form, has evolved into a more specific 
procedure aimed at obtaining precise information that will help 
patients to express their free, informed wishes. 
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